- Conditions
- Autism, Attention Deficit Hyperactivity Disorder
- Interventions
- Transcranial Photobiomodulation
- Device
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 9 Years to 17 Years
- Enrollment
- 38 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Dec 7, 2025 · Synced May 22, 2026, 12:48 AM EDT